» Articles » PMID: 31445519

Endometrium and Endometriosis Tissue Mitochondrial Energy Metabolism in a Nonhuman Primate Model

Overview
Publisher Biomed Central
Date 2019 Aug 26
PMID 31445519
Citations 15
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Endometriosis is the growth of uterine lining (endometrium) outside of the uterus. In other chronic inflammatory diseases, mitochondrial dysfunction is suspected of playing a role in disease pathogenesis. However, little is known about endometriosis mitochondrial function or its effects on tissue metabolism. The objectives of this study were to analyze mitochondrial function in nonhuman primate (NHP) endometrium and endometriosis tissue and to identify the metabolic features of these tissues that may contribute to disease.

Methods: Mitochondrial function in endometriosis tissue and endometrium was measured using mitochondrial respirometry analysis to determine if changes in oxidative phosphorylation exist in endometrium and endometriosis tissue compared to control endometrium from clinically healthy NHPs. Targeted metabolomics and multidimensional statistical analysis were applied to quantify key metabolites in energy and amino acid biosynthesis pathways.

Results: Mitochondrial respirometry assays showed endometrium from NHPs with endometriosis had reduced complex II-mediated oxygen consumption rates (OCR) across all energy states (basal, p = 0.01; state 3, p = 0.02; state 3u, p = 0.04; state 4o, p = 0.008) and endometriosis tissue had reduced state 3, complex I-mediated OCR (p = 0.02) and respiratory control rates (p = 0.01) compared to normal endometrium. Targeted metabolomics performed on tissue revealed carnitine (p = 0.001), creatine phosphate (p = 0.01), NADH (p = 0.0001), FAD (p = 0.001), tryptophan (p = 0.0009), and malic acid (p = 0.005) were decreased in endometriosis tissue compared to normal endometrium samples. FAD (p = 0.004), tryptophan (p = 0.0004) and malic acid (p = 0.03) were significantly decreased in endometrium from NHPs with endometriosis compared to normal endometrium. Significant metabolites identified in endometriosis and endometrium samples from animals with endometriosis were part of amino acid biosynthesis or energy metabolism pathways.

Conclusions: Here, endometrial mitochondrial energy production and metabolism were decreased in endometrium and endometriosis tissue. Decreased mitochondrial energy production may be due to oxidative stress-induced damage to mitochondrial DNA or membranes, a shift in cell metabolism, or decreased energy substrate; however, the exact cause remains unknown. Additional research is needed to determine the implications of reduced mitochondrial energy production and metabolism on endometriosis and endometrium.

Citing Articles

The Current Applications of Metabolomics in Understanding Endometriosis: A Systematic Review.

Collie B, Troisi J, Lombardi M, Symes S, Richards S Metabolites. 2025; 15(1).

PMID: 39852392 PMC: 11767062. DOI: 10.3390/metabo15010050.


Hypoxic conditions affect transcriptome of endometrial stromal cells in endometriosis and promote TGFBI axis.

Sarsenova M, Boggavarapu N, Kask K, Modhukur V, Samuel K, Karro H Front Endocrinol (Lausanne). 2025; 15:1465393.

PMID: 39744178 PMC: 11688238. DOI: 10.3389/fendo.2024.1465393.


Endometriotic lesions exhibit distinct metabolic signature compared to paired eutopic endometrium at the single-cell level.

Sarsenova M, Lawarde A, Pathare A, Saare M, Modhukur V, Soplepmann P Commun Biol. 2024; 7(1):1026.

PMID: 39169201 PMC: 11339455. DOI: 10.1038/s42003-024-06713-5.


Proteomics approach to discovering non-invasive diagnostic biomarkers and understanding the pathogenesis of endometriosis: a systematic review and meta-analysis.

Azeze G, Wu L, Alemu B, Lee W, Fung L, Cheung E J Transl Med. 2024; 22(1):685.

PMID: 39061077 PMC: 11282838. DOI: 10.1186/s12967-024-05474-3.


The mysterious association between adiponectin and endometriosis.

Zhao Y, Ren Y, Li B, Wei C, Yu B Front Pharmacol. 2024; 15:1396616.

PMID: 38813109 PMC: 11133721. DOI: 10.3389/fphar.2024.1396616.


References
1.
Bulun S, Yang S, Fang Z, Gurates B, Tamura M, Sebastian S . Estrogen production and metabolism in endometriosis. Ann N Y Acad Sci. 2002; 955:75-85; discussion 86-8, 396-406. DOI: 10.1111/j.1749-6632.2002.tb02767.x. View

2.
Lambrinoudaki I, Augoulea A, Christodoulakos G, Economou E, Kaparos G, Kontoravdis A . Measurable serum markers of oxidative stress response in women with endometriosis. Fertil Steril. 2008; 91(1):46-50. DOI: 10.1016/j.fertnstert.2007.11.021. View

3.
Xia J, Psychogios N, Young N, Wishart D . MetaboAnalyst: a web server for metabolomic data analysis and interpretation. Nucleic Acids Res. 2009; 37(Web Server issue):W652-60. PMC: 2703878. DOI: 10.1093/nar/gkp356. View

4.
Hardas S, Butterfield D, Sultana R, Tseng M, Dan M, Florence R . Brain distribution and toxicological evaluation of a systemically delivered engineered nanoscale ceria. Toxicol Sci. 2010; 116(2):562-76. DOI: 10.1093/toxsci/kfq137. View

5.
Giudice L . Clinical practice. Endometriosis. N Engl J Med. 2010; 362(25):2389-98. PMC: 3108065. DOI: 10.1056/NEJMcp1000274. View